Abstract
Objectives This prospective study aimed to examine the association of job demands, job control, and the lack of supervisor and coworker support with side effects after receiving COVID-19 vaccination in a sample of employees in Japan.
Methods The data were retrieved from an online panel of full-time employees (E- COCO- J). The analysis included participants who were employed and were not vaccinated at baseline (June 2021) but received vaccination at a four-month follow-up (October 2021). An 11-item scale measured the side effects of COVID-19 vaccines. Four types of psychosocial working conditions (i.e., job demands, job control, and supervisor and coworker support) were measured using the Brief Job Stress Questionnaire (BJSQ). Multiple linear regression analyses were conducted to examine the relationship between the psychosocial working conditions and side effects of COVID-19 vaccines, adjusting for gender, age, educational attainment, marital status, occupation, chronic disease, dose of vaccination, anxiety from potential side effects of vaccines, fear and worry about COVID-19, and psychological distress at baseline.
Results Overall, 747 employees were included in the analysis. The average number of side effects was 3.78 (SD=2.19): Arm pain (81.1%), fatigues (64.1%), muscle pains (63.3%), and fever (37.5 degrees Celsius +) (53.5%) were reported more frequently. Coworker support score was significantly and negatively associated with the numbers of side effects (standardized β=-0.122, p=0.017). Women, young age, second time vaccination, and high psychological distress were significantly associated with several side effects.
Conclusions Employees with low coworker support may be more likely to have side effects after COVID-19 vaccinations. The findings of this study could inform employees with low coworker support that increasing workplace support may reduce the side effects.
Highlights
⍰ The effect of poor psychosocial working conditions on side effects after COVID-19 vaccinations was unknown.
⍰ Poor coworker support at baseline was significantly associated with increased side effects after COVID-19 vaccinations.
⍰ Informing workers with low coworker support about the findings may help them prepare for the side effect and motivate them to improve coworker support to reduce side effects.
Competing Interest Statement
NK received grants from SB AtWork Corp, Fujitsu Ltd, and TAK Ltd, personal fees from the Occupational Health Foundation, SB AtWork Corp, RIKEN, Japan Aerospace Exploration Agency (JAXA), Japan Dental Association, Sekisui Chemicals, Junpukai Health Care Center, Osaka Chamber of Commerce and Industry, outside the submitted work. RK received grants from Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science (JSPS), personal fees from SATORI electric CO., LTD, NXP Semiconductors, RIKEN, Toyotsu Chemiplas, Mitsubishi Materials Corporation outside the submitted work.”
Funding Statement
The 2021 Health, Labour and Welfare Policy Research Grants; The Japan Ministry of Health, Labour, and Welfare; and an internal fund of the Department of Mental Health, Graduate School of Medicine at the University of Tokyo, supported this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Research Ethics Committee of the Graduate School of Medicine/Faculty of Medicine, The University of Tokyo, approved this study, No. 10856-(2)(3)(4)(5).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
nasasaki-tky{at}umin.ac.jp
urk{at}ohs.adm.u-tokyo.ac.jp
ktsuno-tky{at}umin.ac.jp
kouima-tky{at}umin.ac.jp
DISCLOSURE
Approval of the research protocol: The Research Ethics Committee of the Graduate School of Medicine/Faculty of Medicine, The University of Tokyo, approved this study, No. 10856-(2)(3)(4)(5).
Informed consent: Online informed consent was obtained from all participants after full disclosure and explanation of the purpose and procedures of this study. We explained that their participation was voluntary, and they could withdraw consent for any reason simply by not completing the questionnaire.
Registry and registration number of the study/trial: N/A.
Animal studies: N/A.
Conflict of interest: NK received grants from SB AtWork Corp, Fujitsu Ltd, and TAK Ltd, personal fees from the Occupational Health Foundation, SB AtWork Corp, RIKEN, Japan Aerospace Exploration Agency (JAXA), Japan Dental Association, Sekisui Chemicals, Junpukai Health Care Center, Osaka Chamber of Commerce and Industry, outside the submitted work. RK received grants from Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science (JSPS), personal fees from SATORI electric CO., LTD, NXP Semiconductors, RIKEN, Toyotsu Chemiplas, Mitsubishi Materials Corporation outside the submitted work.”
Funding/Support: The 2021 Health, Labour and Welfare Policy Research Grants; The Japan Ministry of Health, Labour, and Welfare; and an internal fund of the Department of Mental Health, Graduate School of Medicine at the University of Tokyo, supported this work.
Role of the Funder/Sponsor: The sponsors had no role in the design and procedures of the study; collection, management, analysis, and interpretation of the data; the preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.
Data availability statement: The data supporting this study’s findings are available from the corresponding author, NK, upon reasonable request.
Data Availability
The data supporting this study's findings are available from the corresponding author, NK, upon reasonable request.
